OVERVIEW INNOVATIONS COMPANY PROFILE OUR EXPERTS FACILITY ENVIRONMENTAL HEALTH & SAFETY OVERVIEW QUALITY CREDENTIALS COA PROCESS FLOW CHARTS EXPIRY/RETEST DATES OVERVIEW SYNTHESIS CERTIFIED SOLUTION STANDARDS CERTIFICATIONS PACKAGING INVENTORY MANAGEMENT AND DISTRIBUTION OEM & PRIVATE LABEL REQUEST QUOTE OVERVIEW CATALOG NEW PRODUCTS REQUEST CUSTOM QUOTE SEARCH COAs/MSDSs ORDERING INFORMATION CATALOG HELP REQUEST CATALOG DOWNLOAD CATALOG NEWSROOM PRODUCTS IN THE NEWS TRADE SHOWS PAPERS AND POSTER PRESENTATIONS CONTACT INFORMATION DISTRIBUTORS CAREERS LOGIN QUICK ORDER ORDER HISTORY PURCHASES BY ITEM ALERTS & NOTIFICATIONS VIEW CART/CHECK OUT
New Safety Concerns for Antipsychotic Treatments READ Study Suggests College Athletes on Performance Enhancers More Likely to Abuse Alcohol & Drugs READ Striving for Greater Traceability in Clinical Laboratory Testing READ Cerilliant Introduces Snap-N-SpikeTM Reference Solutions of Immunosuppressant Drugs READ Effectiveness of Drug Combinations in the Treatment of Chronic Pain READ Routine Urine Tests for Exam Students of the Future? READ Cerilliant Introduces Multi-Component Reference Standard for Pain Management Testing READ Diabetes Drug as a Potential Treatment for Cancer READ Research Suggests Intravenous Ketamine Reduces Suicidality in Depressed Patients READ Expert Indicates EPA Pesticide Exposure Test Too Short and Overlooks Long-Term Effects READ Jackson Death Ruled a Homicide READ FDA Examines Orlistat over Liver Damage Reports READ Report Finds Physicians Lack Knowledge of Off-Label Drug Use and FDA Approval Status READ Past Meth Lab Homes Sicken Unsuspecting Owners READ Atypical Antipsychotics Study Offers New Consideration for Clozapine READ FDA Adds Additional Requirements and Stronger Warnings to Propoxyphene READ News Article Highlights Long-Term Health Effects of Benzodiazepines Cerilliant Releases Labeled Hormone Reference Standards of Progesterone and 17β-Estradiol READ FDA Announces Black Box Warnings for Chantix® and Zyban® READ FDA Panel Recommends Removal of VicodinTM and PercocetTM READ Salvia Restrictions Increasing in the U.S. READ Cerilliant Introduces Certified Reference Materials of Reb-A (Stevia) in Solution READ Cerilliant Releases Labeled Benzyl and Phenyl Piperazine Reference Standards READ British Academics Provide Warnings on Athletes’ Use of Prescription Drugs READ Potentially Effective Male Contraception with Injectable Testosterone READ Cerilliant Introduces 25-Hydroxy Vitamin D3 Certified Reference Solution READ Inadequate Vitamin D Levels and High Use of Narcotics in Patients with Chronic Pain READ Texas Defense Lawyers Challenging Blood Alcohol Testing in DWI Cases READ FDA Requiring REMS for Certain Opioid Drugs REMS Elements May Include Requirement for Patient Monitoring READ Proton Pump Inhibitors May Reduce Plavix® ’s Effectiveness READ Viagra® ’s Potential Heart Benefit: Protection from High Blood Pressure READ Use of Antidepressants in Treating Chronic Pain READ Antibiotics Implicated As Single Largest Class of Drugs Causing Liver Injury READ FDA Adds More Diet Pills to Alert List READ Lower Potency of Analgesic Drugs in Females Than in Males READ Cerilliant Introduces Salvinorin A Certified Solution Standard READ Drugs Identified As Needing Urgent Study of Off-label Use READ Amphetamines and Cocaine Addiction READ An Update on Pharmaceuticals and Personal Care Products in Drinking Water – EPA Methods 1694 and 1698 READ Snurf Pills and Dextromethorphan READ New Study Shows Gender Factor in SSRI Antidepressant Treatment READ DEA Releases its NFLIS 2007 Annual Report READ Antipsychotic Drugs Increase Stroke Risk READ Study Finds Over 10 Million Americans With Weekly Opiate Use READ Methadone Now Fastest Growing Cause of US Narcotics Deaths READ Fatal Medication Errors at Home Due to Prescription Painkillers READ Cerilliant Introduces New Opiate Analytical Reference Standards READ Cerilliant Releases Oxymorphone-3-β-D-Glucuronide Analytical Reference Standard READ Cerilliant Offers Comprehensive List of Steroids READ Residual Solvents <467> Changes Impact Pharmaceutical Manufacturers READ Cerilliant Introduces New Cannabinoid Reference Standards READ Cerilliant Introduces New Cannabinoid Reference Standards READ Certified Solution Standards for Post Traumatic Stress Disorder Drugs READ Chemical Reference Standards for Explosive Materials Reclassified for Easier Shipping READ Growing Interest in Drinking Water Standards - EPA Methods 1694 and 1698 READ Cerilliant Introduces New Nonbenzodiazepine Drug Standard READ FDA and Antiepileptic Medications READ EPA Method 1699 READ Texas High School Anabolic Steroid Testing READ
© 2008 Cerilliant Corporation 811 Paloma Drive, Suite A | Round Rock, Texas 78665 Home | About Us | Quality | Capabilities | Products | News/Events | Contact | Sitemap | Privacy Policy